Cardiothoracic Surgery

Cardiothoracic Surgery Expert Witness

Cardiothoracic surgery expert witnesses evaluate disputes involving surgical procedures on the heart, lungs, esophagus, mediastinum, and chest wall. While sharing overlap with cardiac surgery, cardiothoracic surgery encompasses the full scope of intrathoracic operations — including pulmonary resections for lung cancer, esophagectomy, mediastinal tumor resection, and surgical management of pleural disease in addition to cardiac procedures. Attorneys rely on cardiothoracic surgery experts when cases involve thoracic operative complications, surgical staging decisions for thoracic malignancies, or the intersection of cardiac and pulmonary surgical management.

When your case involves a patient who underwent video-assisted thoracoscopic lobectomy for lung cancer and developed a bronchopleural fistula postoperatively because the bronchial stump closure was inadequate, a cardiothoracic surgery expert can evaluate whether the stapling technique, stump reinforcement, and postoperative surveillance met accepted thoracic surgical standards. If a patient with esophageal cancer underwent transthoracic esophagectomy and developed an anastomotic leak that was not recognized for several days despite clinical signs of sepsis, the expert assesses whether postoperative monitoring, leak detection protocols, and surgical technique were appropriate. In cases where a patient is found to have had a resectable lung tumor downstaged to unresectable due to a prolonged delay in surgical referral after biopsy-proven diagnosis, the expert evaluates whether the referral timeline met oncologic surgical standards. When a mediastinal mass biopsy results in injury to the phrenic nerve or thoracic duct, the expert reviews the operative approach and whether the anatomic risk was communicated and managed according to the standard of care. For damages testimony, the expert projects the long-term consequences of thoracic surgical complications — including permanent vocal cord paralysis requiring medialization laryngoplasty and voice therapy, chronic respiratory impairment from post-pneumonectomy syndrome or restrictive lung disease after extensive resection, and reduced exercise capacity measured by pulmonary function testing and six-minute walk distance — providing the foundation for a life care plan or damages calculation. The expert quantifies the lifetime cost of supplemental oxygen, pulmonary rehabilitation, and the vocational impact of permanent pulmonary disability.

A cardiothoracic surgery expert witness evaluates preoperative pulmonary function testing and split-function studies for lung resection candidacy, CT and PET staging interpretation for thoracic malignancies, operative technique for open and minimally invasive thoracic procedures, and intraoperative decision-making including conversion from VATS to thoracotomy. They review management of air leaks, chest tube management protocols, postoperative respiratory failure, chylothorax, and recurrent laryngeal nerve injury. For esophageal surgery, the expert assesses conduit selection, anastomotic technique, and the management of anastomotic complications. The expert also evaluates whether multidisciplinary tumor board review occurred for oncologic cases and whether neoadjuvant therapy was appropriately considered before surgical resection. For combined cardiac and thoracic cases — such as a patient requiring both valve surgery and lung resection — the expert assesses the staging of procedures and the management of the compounded perioperative risk. Anchor Medical Expert Consulting matches attorneys with practicing cardiothoracic surgeons whose operative scope aligns with the specific procedure at issue, whether purely thoracic, purely cardiac, or combined. For long-term prognosis and damages analysis, the expert evaluates permanent pulmonary impairment using serial spirometry, diffusion capacity measurements, and cardiopulmonary exercise testing. They project the lifetime costs of supplemental oxygen therapy, pulmonary rehabilitation, bronchodilator medications, and surveillance imaging for recurrence in oncologic cases. The expert assesses permanent voice dysfunction using the Voice Handicap Index and projects future laryngeal procedures, and calculates disability ratings for thoracic surgical complications using the AMA Guides respiratory impairment classification.